Top

Published in:

01-10-2010 | Original Paper

Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet’s disease

Authors: Peizeng Yang, Wang Fang, Xiangkun Huang, Hongyan Zhou, Li Wang, Bo Jiang

Published in: International Ophthalmology | Issue 5/2010

Abstracts

Purpose To quantitatively evaluate aqueous flare and cells in patients with Behcet’s disease. Methods This study included 30 Behcet’s patients (52 eyes) with active uveitis. The patients were treated with immunosuppressive agents. Aqueous flare and cells were quantified using the laser flare-cell photometry before treatment and 1 and 2 months after treatment. Result Before treatment, mean aqueous flare (ph/ms) in Behcet’s eyes was 25.7 ± 20.5. After treatment, flare values were significantly reduced after 1 and 2 months compared with those before treatment. No significant difference was found between flare values after 1 and 2 months. Before treatment, mean cell counts (cells/0.5 mm³) in Behcet’s eyes were 23.2 ± 29.4. After treatment, cell counts were also significantly reduced after 1 and 2 months compared with those before treatment. Cell counts were further significantly reduced from 1 to 2 months. Conclusion Both aqueous flare and cells were significantly increased in Behcet’s patients with active uveitis and improved after a two-month treatment. Breakdown of the blood–aqueous barrier lasts longer than aqueous cells in these patients.

Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175–1183CrossRefPubMed

Evereklioglu C (2005) Current concepts in the etiology and treatment of Behcet disease. Surv Ophthalmol 50:297–350CrossRefPubMed

Michelson JB, Friedlaender MH (1990) Behcet’s disease. Int Ophthalmol Clin 30:271–277CrossRefPubMed

Yang P, Zhang Z, Zhou H, Li B et al (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30:943–948CrossRefPubMed

Yang P, Fang W, Meng Q, Ren Y et al (2008) Clinical features of Chinese patients with Behçet’s disease. Ophthalmology 115:312–318 e4CrossRefPubMed

Guex-Crosier Y, Pittet N, Herbort CP (1994) Evaluation of laser flare-cell photometry in the appraisal and management of intraocular inflammation in uveitis. Ophthalmology 101:728–735PubMed

Guex-Crosier Y, Pittet N, Herbort CP (1995) Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment. Ophthalmology 102:613–621PubMed

Herbort CP, Guex-Crosier Y, de Ancos E, Pitte N (1997) Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 104:64–71 discussion 71–72PubMed

Amino K, Yamakawa R (2000) Long-term results of out-of-the-bag intraocular lens implantation. J Cataract Refract Surg 26:266–270CrossRefPubMed

10.

Gonzales CA, Ladas JG, Davis JL, Feuer WJ et al (2001) Relationships between laser flare photometry values and complications of uveitis. Arch Ophthalmol 119:1763–1769PubMed

11.

Nguyen NX, Langenbucher A, Seitz B, Graupner M et al (2001) Blood–aqueous barrier breakdown after penetrating keratoplasty with simultaneous extracapsular cataract extraction and posterior chamber lens implantation. Graefes Arch Clin Exp Ophthalmol 239:114–117CrossRefPubMed

12.

Davis JL, Dacanay LM, Holland GN, Berrocal AM et al (2003) Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol 135:763–771CrossRefPubMed

13.

Eter N, Spitznas M, Sbeity Z, Vogel A (2004) Evaluation of the blood–aqueous barrier by laser flare cell photometry following retinal cryocoagulation. Graefes Arch Clin Exp Ophthalmol 242:120–124CrossRefPubMed

14.

Nguyen NX, Küchle M, Naumann GOH (2005) Quantification of blood–aqueous barrier breakdown after phacoemulsification in Fuchs’ heterochromic uveitis. Ophthalmologica 219:21–25CrossRefPubMed

15.

Okada AA (2006) Behcet’s disease: general concepts and recent advances. Curr Opin Ophthalmol 17:551–556CrossRefPubMed

16.

International Study Group for Behcet’s Disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080

17.

Fang W, Zhou H, Yang P, Huang X et al (2007) Aqueous flare and cells in Fuchs syndrome. Eye advance online publication, 26 October 2007. doi:10.1038/sj.eye.6702991

18.

Fang W, Zhou H, Yang P, Huang X et al (2008) Longitudinal quantification of aqueous flare and cells in Vogt–Koyanagi–Harada disease. Br J Ophthalmol 92:182–185CrossRefPubMed

19.

Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO et al (2005) Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol 50:27–47CrossRefPubMed

Title: Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet’s disease
Authors: Peizeng Yang
Wang Fang
Xiangkun Huang
Hongyan Zhou
Li Wang
Bo Jiang
Publication date: 01-10-2010
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 5/2010
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-008-9229-z

At a glance: The STEP trials

Springer Medicine

Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet’s disease

Abstracts

At a glance: The STEP trials

Springer Medicine

Abstracts

Please log in to get access to this content

Other articles of this Issue 5/2010

Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: interventional case series

Sensitivity of laser flare photometry compared to slit-lamp cell evaluation in monitoring anterior chamber inflammation in uveitis

Cat-scratch disease: ocular manifestations and visual outcome

Cytomegalovirus retinitis after low-dose intravitreous triamcinolone acetonide in an immunocompetent patient: a warning for the widespread use of intravitreous corticosteroids

Clinical features and prognostic factors in Fuchs’ uveitis

Unilateral acute retinal necrosis in a multiple sclerosis patient treated with high-dose systemic steroids